Statistics for Triple Regimen with Rituximab, Plasmapheresis and Intravenous Immunoglobulin in the Treatment of Dialysis Dependent Acute Humoral-Mediated Rejection in Kidney Grafts
Total visits
| views | |
|---|---|
| Triple Regimen with Rituximab, Plasmapheresis and Intravenous Immunoglobulin in the Treatment of Dialysis Dependent Acute Humoral-Mediated Rejection in Kidney Grafts | 100 |
Total visits per month
| views | |
|---|---|
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
File Visits
| views | |
|---|---|
| RPNH 2006 131.pdf(legacy) | 162 |
| RPNH 2006 131.pdf | 7 |
Top country views
| views | |
|---|---|
| United States | 59 |
| China | 10 |
| Portugal | 8 |
| Russia | 5 |
| Italy | 4 |
| Canada | 3 |
| Germany | 2 |
| France | 2 |
| United Kingdom | 2 |
| Japan | 2 |
| Israel | 1 |
| Iran | 1 |
| Mexico | 1 |